ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
ARch Biopartners Inc (QB)

ARch Biopartners Inc (QB) (ACHFF)

1,32
0,02
(1,54%)
Fermé 23 Janvier 10:00PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
1,32
Prix Achat
1,00
Prix Vente
2,00
Volume échangé
1 904
1,3101 Fourchette du Jour 1,32
0,8925 Plage de 52 semaines 1,88
Cap du marché
Clôture Veille
1,30
Ouverture
1,3101
Dernière Transaction
900
@
1.32
Dernière heure de transaction
Volume financier
US$ 2 509
VWAP
1,3175
Volume moyen (3 m)
10 597
Actions en circulation
64 650 633
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-36,89
Bénéfice par action (BPA)
-0,05
Chiffre d'affairess
1,98M
Bénéfice net
-3,33M

À propos de ARch Biopartners Inc (QB)

Secteur
Coml Physical, Biologcl Resh
Industrie
Advertising Agencies
Siège social
Toronto, Ontario, Can
Fondé
2010
ARch Biopartners Inc (QB) est coté dans le secteur Coml Physical, Biologcl Resh de la OTCMarkets avec le ticker ACHFF. Le dernier cours de clôture d'ARch Biopartners (QB) était de US$1,30. Au cours de la dernière année, les actions de ARch Biopartners (QB) ont été négociées dans une fourchette de prix de US$ 0,8925 à US$ 1,88.

ARch Biopartners (QB) compte actuellement 64 650 633 actions en circulation. La capitalisation boursière d'ARch Biopartners (QB) est de US$84,05 million. ARch Biopartners (QB) a un ratio cours/bénéfice (ratio PE) de -36.89.

ACHFF Dernières nouvelles

Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19

TORONTO, Canada -- November 5, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that...

First Patient Dosed in Phase II Trial to Treat Complications in COVID-19

TORONTO, Ontario, CANADA -- October 16, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF...

Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.

TORONTO, Canada -- June 8, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company...

Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial

TORONTO, Canada -- May 8, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company...

Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation

TORONTO, Canada -- April 24, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.321.34011.2785381.30812871CS
40.021.538461538461.31.391.24811681491.31863439CS
12-0.06-4.347826086961.381.511.1105971.33429681CS
260.217.85714285711.121.52250.892594731.28692488CS
520.21519.45701357471.1051.880.8925131881.37260475CS
156-1.4-51.47058823532.723.380.72129011.48670402CS
2600.617387.84687633410.70274.130.525132611.51735299CS

ACHFF - Frequently Asked Questions (FAQ)

What is the current ARch Biopartners (QB) share price?
The current share price of ARch Biopartners (QB) is US$ 1,32
How many ARch Biopartners (QB) shares are in issue?
ARch Biopartners (QB) has 64 650 633 shares in issue
What is the market cap of ARch Biopartners (QB)?
The market capitalisation of ARch Biopartners (QB) is USD 84,05M
What is the 1 year trading range for ARch Biopartners (QB) share price?
ARch Biopartners (QB) has traded in the range of US$ 0,8925 to US$ 1,88 during the past year
What is the PE ratio of ARch Biopartners (QB)?
The price to earnings ratio of ARch Biopartners (QB) is -36,89
What is the cash to sales ratio of ARch Biopartners (QB)?
The cash to sales ratio of ARch Biopartners (QB) is 61,89
What is the reporting currency for ARch Biopartners (QB)?
ARch Biopartners (QB) reports financial results in CAD
What is the latest annual turnover for ARch Biopartners (QB)?
The latest annual turnover of ARch Biopartners (QB) is CAD 1,98M
What is the latest annual profit for ARch Biopartners (QB)?
The latest annual profit of ARch Biopartners (QB) is CAD -3,33M
What is the registered address of ARch Biopartners (QB)?
The registered address for ARch Biopartners (QB) is 27 ST. CLAIR AVENUE EAST, P.O. BOX 305, TORONTO, ONTARIO, M5V 1M1
What is the ARch Biopartners (QB) website address?
The website address for ARch Biopartners (QB) is archbiopartners.com
Which industry sector does ARch Biopartners (QB) operate in?
ARch Biopartners (QB) operates in the ADVERTISING AGENCIES sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RTNBroot9B Holdings Inc (CE)
US$ 0,003003
(300 200,00%)
333
CTRYFCountry Garden Holdings Company Limited (CE)
US$ 0,075
(37 400,00%)
1,69k
CNQQFClean TeQ Water Ltd (PK)
US$ 0,18
(25 614,29%)
425
QBIOQ BioMed Inc (CE)
US$ 0,0002
(19 900,00%)
692
MGTIMGT Capital Investments Inc (CE)
US$ 0,0002
(19 900,00%)
15,63k
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0,000001
(-99,99%)
150
CONNQConns Inc (CE)
US$ 0,000001
(-99,98%)
250
SPECSpectaire Holdings Inc (CE)
US$ 0,000001
(-99,90%)
6,02k
EGOCEnergy One Corporation (CE)
US$ 0,000001
(-99,90%)
21,8k
GRTSQGritstone bio Inc (CE)
US$ 0,000001
(-99,90%)
223,35k
PDGOParadigm Oil and Gas Inc (PK)
US$ 0,0001
(-50,00%)
574,25M
RDARRaadr Inc (PK)
US$ 0,001
(-9,09%)
280,1M
COSGCosmos Group Holdings Inc (PK)
US$ 0,0002
(19 900,00%)
267,1M
HMBLHUMBL Inc (PK)
US$ 0,0008
(-11,11%)
251,13M
ASIIAccredited Solutions Inc (PK)
US$ 0,0005
(0,00%)
187,29M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock